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Online Supplementary Figure S1 . Clotting time and lysis time changes as a function of the percentage of activated MNC. Mixtures of LPS-MNC and C-MNC were prepared in order to obtain the indicated percentage of LPS-MNC. Cell numbers were 3×10 6 /mL in all preparations. Clot formation and t-PA-induced fibrinolysis of recalcified CTI-plasma were evaluated by a turbidimetric assay as reported in Methods. A single experiment is shown.
Online Supplementary Figure S2 . Role of TF, thrombin and TAFI in the inhibition of fibrinolysis by LPS-MNC. t-PA-induced lysis of CTI-plasma clots was measured in the presence of C-MNC and LPS-MNC. The sample containing LPS-MNC was also tested after treatment of cells with an anti-TF monoclonal antibody (Anti-TF), after treatment of plasma with the anti-TAFI monoclonal MAT12D11, or in the presence of the TAFIa inhibitor PTCI. Results represent the mean of 2 experiments with cells from different donors.
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Online Supplementary Figure S3 . Inhibition of fibrinolysis by adherent monocytes. Control (C-M) and LPS-stimulated adherent monocytes (LPS-M) were prepared as reported in Methods. Clots were generated onto the surface of adherent cells by adding t-PA-containing recalcified CTI-plasma and the lysis time was measured by the changes in OD.
LPS-M were also tested after treatment of adherent cells with anti-TF monoclonal antibody (LPS + Anti-TF), or in the presence of the TAFIa inhibitor PTCI (LPS-M + PTCI). A single experiment is shown. The anti-TAFI monoclonal antibody was not tested in this experiment.
